Register or Sign in to Save this opportunity, or Send an Inquiry.
SJ-BRV Antiobesity Immunodrug_SJ BIOMED Inc
Korea Health Industry Development Institute (KHIDI) South Korea flag South Korea
Abstract ID:
SJ-BRV is a novel therapeutic and prophylactic immunodrug for the treatment and prevention of obesity
Send an Inquiry
RE:
Participants
You

SJ-BRV is novel therapeutic and prophylactic immunodrug for the treatment and prevention of obesity by controlling lipid metabolism in a stage of storage. The key to the SJ-BRV vaccine is to trick the immune system into making antibodies against self antigens. SJ-BRV works by eliciting antibodies that block the binding of lipids in receptors in the adipose tissue thus preventing lipid storage in the adipose tissue.


-          Working on process development on candidate protein SJ-BRV


-          Formulation Study in preparation


-          Preparing non-clinical toxicity study design and clinical design

FEATURED
Last Updated Oct 2017
Technology Type THERAPEUTIC
Phase of Development CLINICAL TRIALS
GOVERNMENT INSTITUTE

Opportunity Contact


Warning: include(js_message_scripts_n2.php) [function.include]: failed to open stream: No such file or directory in /home/pharmalicensing/public_html/detail.php on line 833

Warning: include() [function.include]: Failed opening 'js_message_scripts_n2.php' for inclusion (include_path='.:/usr/lib/php:/usr/local/lib/php') in /home/pharmalicensing/public_html/detail.php on line 833